Sign In
to Vote &
Create Storyboards.
 

Water Pill May Be Viable to Test as Alzheimer's Treatment

Neuroscience News - 11 Oct 2021 20:22
Water Pill May Be Viable to Test as Alzheimer's Treatment Bumetanide, an FDA-approved potent diuretic used to treat fluid retention caused by heart, kidney, and liver disease may lower the risk of developing Alzheimer's disease for those with a genetic predisposition.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard